Journal
NEUROTOXICITY RESEARCH
Volume 8, Issue 1-2, Pages 63-80Publisher
SPRINGER
DOI: 10.1007/BF03033820
Keywords
AIDS; chemokines; mu-opioid receptors; neurons; astroglia; microglia; neuroimmunology; CNS inflammation
Categories
Funding
- NCRR NIH HHS [P20RR015592] Funding Source: Medline
- NIDA NIH HHS [R01 DA013728, DA13728, T32 DA16176-01, DA13559, R01 DA013559] Funding Source: Medline
Ask authors/readers for more resources
Opiate drug abuse, through selective actions at p opioid receptors (NIOR), exacerbates the pathogenesis of human immunodeficiency virus-1 (HIV-1) in the CNS by disrupting glial homeostasis, increasing inflammation, and decreasing the threshold for proapoptotic events in neurons. Neurons are affected directly and indirectly by opiate-HIV interactions. Although most opiates drugs have some affinity for kappa (KOR) and/or delta (DOR) opioid receptors, their neurotoxic effects are largely mediated through MOR. Besides direct actions on the neurons themselves, opiates directly affect MOR-expressing astrocytes and microglia. Because of their broad-reaching actions in glia, opiate abuse causes widespread metabolic derangement, inflammation, and the disruption of neuron-glial relationships, which likely contribute to neuronal dysfunction, death, and HIV encephalitis. In addition to direct actions on neural cells, opioids modulate inflammation and disrupt normal intercellular interactions among immunocytes (macrophages and lymphocytes), which on balance further promote neuronal dysfunction and death. The neural pathways involved in opiate enhancement of HIV-induced inflammation and cell death, appear to involve MOR activation with downstream effects through PI3-kinase/Akt and/or MAPK signaling, which suggests possible targets for therapeutic intervention in neuroAIDS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available